Evidence map›Paper›PMID 35493404›Full record

ArticleSSM - population health2022

Factors associated with the risk perception of COVID-19 infection and severe illness: A cross-sectional study in Japan.

Megumi Adachi, Michio Murakami, Daisuke Yoneoka, Takayuki Kawashima, Masahiro Hashizume, Haruka Sakamoto, Akifumi Eguchi, Cyrus Ghaznavi, Stuart Gilmour, Satoshi Kaneko and 6 more

Abstract read
In one paragraph

Article in SSM - population health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Preventive Behaviors and Information Sources during COVID-19 Pandemic: A Cross-Sectional Study in Japan.International journal of environmental research and public health · 2022
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Megumi AdachiDepartment of Health Policy and Management, School of Medicine, Keio University, Tokyo, Japan.
Michio MurakamiDivision of Scientific Information and Public Policy, Center for Infectious Disease Education and Research, Osaka University, Osaka, Japan.
Daisuke YoneokaDepartment of Health Policy and Management, School of Medicine, Keio University, Tokyo, Japan.
Takayuki KawashimaDepartment of Health Policy and Management, School of Medicine, Keio University, Tokyo, Japan.
Masahiro HashizumeDepartment of Global Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Haruka SakamotoDepartment of Global Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Akifumi EguchiDepartment of Health Policy and Management, School of Medicine, Keio University, Tokyo, Japan.
Cyrus GhaznaviDepartment of Health Policy and Management, School of Medicine, Keio University, Tokyo, Japan.
Stuart GilmourGraduate School of Public Health, St. Luke's International University, Tokyo, Japan.
Satoshi KanekoDepartment of Ecoepidemiology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
Hiroyuki KunishimaDepartment of Infectious Diseases, St. Marianna University School of Medicine, Kanagawa, Japan.
Keiko Maruyama-SakuraiDepartment of Health Policy and Management, School of Medicine, Keio University, Tokyo, Japan.
Yuta TanoueDepartment of Global Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Yoshiko YamamotoNational Center for Child Health and Development, Tokyo, Japan.
Hiroaki MiyataDepartment of Health Policy and Management, School of Medicine, Keio University, Tokyo, Japan.
Shuhei NomuraDepartment of Health Policy and Management, School of Medicine, Keio University, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding COVID-19 risk perception may help inform public health messaging aimed at encouraging preventive measures and improving countermeasures against the pandemic. We conducted an online survey of 29,708 Japanese adults in February 2021 and estimated the associations between COVID-19 risk perception and a broad array of individual factors. Two logistic regressions were constructed to estimate factors associated with the risk perception of COVID-19 (defined as responding that one might become infected within the next 6 months), and of severe illness among those who responded that they might become infected (defined as responding that one would become severely ill). After adjusting for covariates, those with a higher perceived risk of the COVID-19 vaccine had higher odds of risk perception for both infection and severe illness. Interestingly, those with higher odds of risk perception of being infected were more likely to report obtaining their information from healthcare workers whereas those with lower odds were more likely to report obtaining their information from the Internet or the government; those with lower odds of risk perception of being severely ill were more likely to report obtaining their information from the Internet. The higher the trust level in the government as a COVID-19 information source, the lower the odds of both risk perception of being infected and becoming severely ill. The higher the trust levels in social networking services as a COVID-19 information source, the higher the odds of risk perception of becoming severely ill. Public health messaging should address the factors identified in our study.

Indexed as

COVID-19InfectionJapanRisk perceptionSevere illness

Identifiers

PMID35493404
PMCPMC9040447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.